Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $64.85 | 3 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $44.17 | 2 | $0 (2023) |
| Vanda Pharmaceuticals Inc. | $20.68 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $24.17 | 1 | Janssen Pharmaceuticals, Inc ($24.17) |
| 2022 | $40.68 | 2 | Vanda Pharmaceuticals Inc. ($20.68) |
All Payment Transactions
3 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/07/2023 | Janssen Pharmaceuticals, Inc | INVEGA TRINZA (Drug) | Food and Beverage | In-kind items and services | $24.17 | General |
| Category: Neuroscience | ||||||
| 08/29/2022 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $20.68 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 07/31/2022 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 44 | 57 | $8,436 | $3,388 |
| 2022 | 1 | 13 | 13 | $2,613 | $1,016 |
All Medicare Procedures & Services
2 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 44 | 57 | $8,436 | $3,388 | 40.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 13 | 13 | $2,613 | $1,016 | 38.9% |
About Dr. Christopher Clark, DO
Dr. Christopher Clark, DO is a Psychiatry healthcare provider based in Augusta, Maine. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/26/2018. The National Provider Identifier (NPI) number assigned to this provider is 1770084634.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Clark, DO has received a total of $64.85 in payments from pharmaceutical and medical device companies, with $24.17 received in 2023. These payments were reported across 3 transactions from 2 companies. The most common payment nature is "Food and Beverage" ($64.85).
As a Medicare-enrolled provider, Clark has provided services to 57 Medicare beneficiaries, totaling 70 services with total Medicare billing of $4,404. Data is available for 2 years (2022–2023), covering 2 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Other Specialties Psychiatry
- Location Augusta, ME
- Active Since 02/26/2018
- Last Updated 05/01/2024
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1770084634
Products in Payments
- INVEGA TRINZA (Drug) $24.17
- HETLIOZ (Drug) $20.68
- INVEGA SUSTENNA (Drug) $20.00
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Augusta
Joseph Mcevoy, Md, MD
Psychiatry — Payments: $113,605
Dr. William Mccall, Md, MD
Psychiatry — Payments: $69,198
Mary Tyson, M.d, M.D
Psychiatry — Payments: $15,524
Dr. Prakash Merai, M.d, M.D
Psychiatry — Payments: $13,057
Elizabeth Messulam, Md, MD
Psychiatry — Payments: $11,031
Dr. Brian Miller, M.d, M.D
Psychiatry — Payments: $9,544